Literature DB >> 6724617

Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells.

E G Ankel, J Zirneski, B J Ring, J S Holcenberg.   

Abstract

High concentrations of Escherichia coli asparaginase (80 U/ml) altered the binding of concanavalin A (Con A) to L 5178Y murine lymphoma cells that are sensitive to the cytotoxic action of this enzyme. Incubation of the asparaginase sensitive line in asparagine-free media or media containing Acinetobacter glutaminase-asparaginase did not alter the Con A binding of these cells. Escherichia coli asparaginase had no effect on Con A binding of two asparaginase resistant L5178Y cell lines that were isolated and maintained in asparagine depleted or asparaginase containing medium. The E. coli asparaginase preparation inhibited protein and glycoprotein biosynthesis to comparable degrees. It did not have proteolytic or glycolytic activity. Escherichia coli asparaginase did not alter the binding of wheat germ, soybean or ricin agglutinins to any of these cell lines. These data suggest that high concentrations of E. coli asparaginase have a specific effect on the Con A receptor in the sensitive line.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724617     DOI: 10.1007/BF02619582

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  26 in total

1.  In vitro blastogenesis inhibited by Erwinia carotovora L-asparaginase.

Authors:  T Han; T Onuma
Journal:  Nat New Biol       Date:  1972-09-13

2.  Isolation and characterization of plasma membranes from an L-asparaginase-sensitive strain of leukemia cells.

Authors:  R F Dods; E Essner; M Barclay
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

3.  Modification of surface topography of lymphocytes by L-asparaginase.

Authors:  I J Fidler; P C Montgomery; J P Cesarini
Journal:  Cancer Res       Date:  1973-12       Impact factor: 12.701

4.  Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin.

Authors:  J D Stobo; A S Rosenthal; W E Paul
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

5.  Isolation, crystallization, and properties of Achromobacteraceae glutaminase-asparaginase with antitumor activity.

Authors:  J Roberts; J S Holcenberg; W C Dolowy
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

6.  Inhibition of glycoprotein synthesis in L5178Y mouse leukaemic cells by L-asparaginase in vitro.

Authors:  H B Bosmann; D Kessel
Journal:  Nature       Date:  1970-05-30       Impact factor: 49.962

7.  Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).

Authors:  R L Dixon; R H Adamson
Journal:  Cancer Chemother Rep       Date:  1965-10

8.  The concanavalin A binding properties of concanavalin A-resistant and -sensitive hamster cell lines.

Authors:  J A Wright; H Ceri
Journal:  Biochim Biophys Acta       Date:  1977-09-05

9.  Synthesis and phosphorylation of plasma membrane proteins of Friend erythroleukemia cells induced to differentiate.

Authors:  Y Gazitt; C Friend
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

10.  Cooperative binding of concanavalin A to thymocytes at 4 degrees C and micro-redistribution of concanavalin A receptors.

Authors:  M Bornens; E Karsenti; S Avrameas
Journal:  Eur J Biochem       Date:  1976-05-17
View more
  2 in total

Review 1.  Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.

Authors:  Maaike Van Trimpont; Evelien Peeters; Yanti De Visser; Amanda M Schalk; Veerle Mondelaers; Barbara De Moerloose; Arnon Lavie; Tim Lammens; Steven Goossens; Pieter Van Vlierberghe
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

Review 2.  Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.

Authors:  Marina V Pokrovskaya; Vadim S Pokrovsky; Svetlana S Aleksandrova; Nikolay N Sokolov; Dmitry D Zhdanov
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.